Medcan will facilitate: • the import and export of products under CGB’s arrangements with third parties (including CannTab Therapeutics Ltd (CannTab)) and Pharmocann Ltd (Pharmocann)) as well as any future products that CGB may want to manufacture or distribute; • the manufacture of CGB’s products (using either its own facility or the facility of third parties); • The storage of and growing of CGB’s unique genetics and seed bank; and • use of a designated area within its facility for a lab for genetic development for CGB, and for manufacturing of oil extraction for CGB
Great question Smoex!
Not sure if the above highlighted in bold applies to your question or if that is on a much smaller basis?
I wonder if the end game still involves Medcan growing for us on scale?
Perhaps if revenue is strong a deal to fit-out Medcan facility can still be struck in the not too distant future?
Perhaps CGL share price will soar & Medcan will take some profits for the fit-out?
All very interesting.
I hope your getting your rest @Neil1959 ...Your going to need it over the coming days/weeks/months.![]()
- Forums
- ASX - By Stock
- CGB
- Ann: Strategic Alliance with TGA & GMP Approved Manufacturer
Ann: Strategic Alliance with TGA & GMP Approved Manufacturer, page-62
-
- There are more pages in this discussion • 156 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online